Brewin Dolphin LTD Merck & Co., Inc. Transaction History

Brewin Dolphin LTD

$2.08 Billion
Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brewin Dolphin LTD holds 36,460 shares of MRK stock, worth $3.57 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

36,460

Previous 34,790 4.8%

Holding current value

$3.57 Million

Previous $2.86 Million 16.43%

% of portfolio

0.16%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 14, 2022	BUY	$83.49 - $94.64 $139,428 - $158,048	1,670 Added 4.8%	36,460 $3.32 Million
Q1 2022 Nov 14, 2022	SELL	$73.51 - $82.4 $117,689 - $131,922	-1,601 Reduced 4.4%	34,790 $2.86 Million
Q4 2021 Nov 14, 2022	BUY	$72.28 - $90.54 $2.63 Million - $3.29 Million	36,391 New	36,391 $2.79 Million
Q3 2021 Nov 09, 2023	BUY	$71.68 - $78.83 $109,096 - $119,979	1,522 Added 1.56%	98,990 $7.44 Billion
Q2 2021 Nov 09, 2023	SELL	$70.31 - $77.77 $121,284 - $134,153	-1,725 Reduced 1.74%	97,468 $7.58 Billion
Q1 2021 Nov 09, 2023	BUY	$68.86 - $81.11 $297,544 - $350,476	4,321 Added 4.55%	99,193 $7.65 Billion
Q4 2020 Nov 09, 2023	BUY	$71.77 - $79.65 $61,076 - $67,782	851 Added 0.91%	94,872 $7.76 Billion
Q3 2020 Nov 09, 2023	BUY	$73.18 - $82.95 $323,089 - $366,224	4,415 Added 4.93%	94,021 $7.8 Billion
Q2 2020 Nov 09, 2023	BUY	$70.42 - $80.13 $12,393 - $14,102	176 Added 0.2%	89,606 $6.93 Billion
Q1 2020 Nov 09, 2023	SELL	$63.36 - $87.82 $16,473 - $22,833	-260 Reduced 0.29%	89,430 $6.88 Billion
Q4 2019 Nov 09, 2023	BUY	$77.58 - $87.54 $13,731 - $15,494	177 Added 0.2%	89,690 $8.16 Billion
Q3 2019 Nov 09, 2023	SELL	$76.08 - $82.93 $101,338 - $110,462	-1,332 Reduced 1.47%	89,513 $7.54 Billion
Q2 2019 Nov 09, 2023	SELL	$69.84 - $81.59 $184,168 - $215,152	-2,637 Reduced 2.82%	90,845 $7.62 Billion
Q1 2019 Nov 09, 2023	BUY	$69.58 - $79.36 $39,312 - $44,838	565 Added 0.61%	93,482 $7.77 Billion
Q4 2018 Nov 09, 2023	BUY	$65.24 - $75.71 $314,456 - $364,922	4,820 Added 5.47%	92,917 $7.1 Billion
Q3 2018 Nov 09, 2023	SELL	$57.69 - $67.84 $135,283 - $159,084	-2,345 Reduced 2.59%	88,097 $6.25 Billion
Q2 2018 Nov 09, 2023	SELL	$50.83 - $59.72 $36,902 - $43,356	-726 Reduced 0.8%	90,442 $5.49 Billion
Q1 2018 Nov 09, 2023	SELL	$50.96 - $59.23 $94,174 - $109,457	-1,848 Reduced 1.99%	91,168 $4.97 Billion
Q4 2017 Nov 09, 2023	SELL	$51.62 - $61.64 $4,077 - $4,869	-79 Reduced 0.08%	93,016 $5.23 Billion
Q3 2017 Nov 09, 2023	BUY	$58.67 - $63.13 $3.32 Million - $3.58 Million	56,635	93,095 $5.96 Billion

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Account

Brewin Dolphin LTD Merck & Co., Inc. Transaction History